Xerthra PRP kit

Xerthra™ PRP kit. THE PLATELET-RICH PLASMA obtained with this kit contains LEUKOCYTES:

• platelets release growth factors, which stimulate regeneration of damaged joint tissues.
• leukocytes injected into the inflamed area serve a regulatory and organizing role.

INDICATIONS: INJURIES AND ADVANCED STAGE OF OA WITH INCREASED INFLAMMATION

Effectiveness of platelet rich plasma therapy depends on platelets amount contained in autologous plasma, because it has a direct impact on the growth factors amount in the product. Only concentration of platelet >1 million PLT/μl ensures the effectiveness of the therapy.
The highest concentration of platelets can only be obtained with specially dedicated devices. XerthraTM separa- tion device allows on average 1.5 million PLT/μl to be obtained, what gives 8 times higher concentration than in the peripheral blood.